홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

2-Dimethylaminopyridine → HCID 178499660, 화합물

HRID 270981
인쇄

반응식

HRID 270981 반응식
[CH:1]1([C:7]2[C:12](=[O:13])[N:11]3[N:14]=[C:15]([C:17](O)=[O:18])[CH:16]=[C:10]3[NH:9][C:8]=2[C:20]2[O:21][CH:22]=[CH:23][CH:24]=2)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[CH:25]([N:28]([CH:31]([CH3:33])[CH3:32])CC)([CH3:27])[CH3:26].CN([C:37]1[CH:42]=[CH:41]C=CN=1)C.Cl.[CH3:44][O:45][C:46](=[O:59])[C@H:47](CC1C2C(=CC=CC=2)NC=1)[NH2:48].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C)C=O.C(OCC)(=O)C>[CH3:44][O:45][C:46](=[O:59])[CH:47]([NH:48][C:17]([C:15]1[CH:16]=[C:10]2[NH:9][C:8]([C:20]3[O:21][CH:22]=[CH:23][CH:24]=3)=[C:7]([CH:1]3[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]3)[C:12](=[O:13])[N:11]2[N:14]=1)=[O:18])[CH2:33][C:31]1[NH:28][C:25]2[C:26]([CH:32]=1)=[CH:41][CH:42]=[CH:37][CH:27]=2
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 218852-DimethylaminopyridineHCID 81531DiisopropylethylamineHCID 2734891Methyl tryptophanate hydrochlorideHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 178524066HCID 178524066, 화합물

생성물 1

HCID 178499660
HCID 178499660, 화합물
수율 39%

시약·촉매·용매 2

HCID 6228Dimethylformamide용매HCID 8857Ethyl Acetate용매

실험 절차

To a solution of 8.2 mg (0.025 mmol) of 6-cyclohexyl-5-furan-2-yl-7-oxo-4,7-dihydro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid in 2 mL of dimethylformamide (DMF) was added 0.009 mL (0.05 mmol) of diisopropylethylamine (DIEA), a few crystals of dimethylaminopyridine (DMAP cat), 7 mg (0.027 mmol) of L-tryptophan methyl ester hydrochloride, followed by 11 mg (0.03 mmol) of HATU, and the resulting mixture was stirred at rt overnight. The reaction mixture was diluted with ethyl acetate, washed with 0.1 N sodium hydroxide solution (2 times) and brine. The separated organic layer was dried over sodium sulfate and concentrated to give a residue which was purified via reverse-phase chromatography (Gilson) to afford desired 2-[(6-cyclohexyl-5-furan-2-yl-7-oxo-4,7-dihydro-pyrazolo[1,5-a]pyrimidine-2-carbonyl)-amino]-3-(1H-indol-2-yl)-propionic acid methyl ester (606). This compound was then converted to 2-[(6-cyclohexyl-5-furan-2-yl-7-oxo-4,7-dihydro-pyrazolo[1,5-a]pyrimidine-2-carbonyl)-amino]-3-(1H-indol-2-yl)-propionic acid (599) via the well known LiOH saponification protocol (39% yield over 2 steps); LC-MS calcd. for C28H27N5O5 [M++H]+: 514.2; found: 514.2.

후처리

  1. washwashed with 0.1 N sodium hydroxide solution (2 times) and brine
  2. dry with materialThe separated organic layer was dried over sodium sulfate
  3. concentrationconcentrated
  4. customto give a residue which
  5. customwas purified via reverse-phase chromatography (Gilson)

출처 및 근거

ORD 기록
ord-d36a53c591ec47bcb8961df05fadeaf7
출처 데이터셋
uspto-grants-2008_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07449488B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트